Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 1;12(9):e063862.
doi: 10.1136/bmjopen-2022-063862.

Does comorbidity burden explain the higher COVID-19 mortality risk among men? A retrospective cross-sectional analysis of a well-defined cohort of patients in Bronx, New York

Affiliations

Does comorbidity burden explain the higher COVID-19 mortality risk among men? A retrospective cross-sectional analysis of a well-defined cohort of patients in Bronx, New York

Aastha Vasa et al. BMJ Open. .

Abstract

Objectives: Men have a higher mortality rate and more severe COVID-19 infection than women. The mechanism for this is unclear. We hypothesise that innate sex differences, rather than comorbidity burden, drive higher male mortality.

Design: Retrospective cohort.

Setting: Montefiore Health System (MHS) in Bronx, New York, USA.

Participants: A cohort population of 364 992 patients at MHS between 1 January 2018 and 1 January 2020 was defined, from which individuals hospitalised during the pre-COVID period (1 January 2020-15 February 2020) (n=5856) and individuals hospitalised during the COVID-19 surge (1 March 2020-15 April 2020) (n=4793) were examined for outcomes. A subcohort with confirmed COVID-19+ hospitalisation was also examined (n=1742).

Primary and secondary outcome measures: Hospitalisation and in-hospital mortality.

Results: Men were older, had more comorbidities, lower body mass index and were more likely to smoke. Unadjusted logistic regression showed a higher odds of death in hospitalised men than women during both the pre-COVID-19 and COVID-19 periods (pre-COVID-19, OR: 1.66 vs COVID-19 OR: 1.98). After adjustment for relevant clinical and demographic factors, the higher risk of male death attenuated towards the null in the pre-COVID-19 period (OR 1.36, 95% CI 1.05 to 1.76) but remained significantly higher in the COVID-19 period (OR 2.02; 95% CI 1.73 to 2.34).In the subcohort of COVID-19+ hospitalised patients, men had 1.37 higher odds of in-hospital death (95% CI 1.09 to 1.72), which was not altered by adjustment for comorbidity (OR remained at 1.38 (95% CI 1.08 to 1.76)) but was attenuated with addition of initial pulse oximetry on presentation (OR 1.26, 95% CI 0.99 to 1.62).

Conclusions: Higher male mortality risk during the COVID-19 period despite adjustment for comorbidity supports the role of innate physiological susceptibility to COVID-19 death. Attenuation of higher male risk towards the null after adjustment for severity of lung disease in hospitalised COVID-19+ patients further supports the role of higher severity of COVID-19 pneumonia in men.

Keywords: COVID-19; epidemiology; public health; respiratory infections.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

References

    1. Wray S, Arrowsmith S. The physiological mechanisms of the Sex-Based difference in outcomes of COVID19 infection. Front Physiol 2021;12:627260. 10.3389/fphys.2021.627260 - DOI - PMC - PubMed
    1. White A. Men and COVID-19: the aftermath. Postgrad Med 2020;132:18–27. 10.1080/00325481.2020.1823760 - DOI - PubMed
    1. Tejpal A, Gianos E, Cerise J, et al. . Sex-Based differences in COVID-19 outcomes. J Womens Health 2021;30:492–501. 10.1089/jwh.2020.8974 - DOI - PMC - PubMed
    1. Kim H, Fox AM, Kim Y, et al. . Is the male disadvantage real? Cross-national variations in sex gaps in COVID-19 incidence and mortality. Glob Public Health 2021;16:1793–803. 10.1080/17441692.2021.1981972 - DOI - PubMed
    1. Kelada M, Anto A, Dave K, et al. . The role of sex in the risk of mortality from COVID-19 amongst adult patients: a systematic review. Cureus 2020;12:e10114. 10.7759/cureus.10114 - DOI - PMC - PubMed